Local Indian Committees to Conduct Annual Inspections of Trial Sites
Clinical trial sites in India will be inspected at least once a year under a new regulatory plan issued by the CDSCO.
Clinical trial sites in India will be inspected at least once a year under a new regulatory plan issued by the CDSCO.
Melding metals to APIs could make drugs easier to deliver according to Sweden's Recipharm which partnered to add a new chemistry to its offering last week.
Brand-to-generic conversions have been blamed for “somewhat softer than expected” financial results at McKesson, though significant FY2014 direct revenue growth has been predicted.
Tension between clinical trial sponsors and CROs in terms of CRO oversight may not be relieved any time soon, but both sides seem intent on arriving at a middle ground where micromanagement stays low and the level of quality remains high.